A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease

Stroke

Volumn 28, Issue 9, 1997, Pages 1739-1743

  Markus, Hugh S ^a   Ali, Nadira ^b   Swaminathan, R ^b   Sankaralingam, A ^b   Molloy, Jane ^b   Powell, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Denmark Hill ^*

Author keywords

Genetics; Homocysteine; Polymorphism (genetics); Relic acid; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOCYSTINURIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; VITAMIN INTAKE;

EID: 0030880665     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.9.1739     Document Type: Article

References (20)

1. Brass LM, Shaker LA. Family history in patients with transient ischemic attacks. Stroke. 1991;22:837-841.
2. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
3. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke. 1994;25:1924-1930.
4. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346: 1395-1398.
5. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1996;48: 536-545.
6. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hvperhomocysteinemia. Am J Hum Genet. 1995; 56:142-150.
7. Kang SS, Passen EL, Ruggie N, Wong PWK, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1996;88:1463-1469.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, Boers GJ, den Heijer M, Kluijtmans LA, Van der Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1996;10:111-113.
9. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
10. Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58:35-41.
11. Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: a case-control study. Circulation. 1996;94: 1812-1814.
12. Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster DM, Rozen R, Evans A, Graham IM, Whitehead AS. Homocysteine and the risk of premature of coronary heart disease: evidence for a common gene mutation. Circulation. 1996;94:2154-2158.
13. Wilcken DEL, Wang XL, Sim AS, McCredie MM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol. 1996;16:878-882.
14. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and the risk of myocardial infarction in US physicians. Circulation. 1996;94: 2410-2416.
15. Press RD, Beamer N, Coull BM. A common mutation in methylenetetrahydrofolate reductase in stroke. Stroke. 1997;28:265. Abstract.
16. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO, Sagnella GA. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 1994;12:955-957.
17. Donnan GA, Norrving B, Bamford JM, Bogousslavsky J. Lacunar and Other Subcortical Infarctions. Oxford. UK: Oxford University Press; 1995.
18. Fiskerstrand T, Refsum H, Kralheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample suitability. Clin Chem. 1993;39:263-271.
19. Harmon DL, Woodside JV, Yarnell JWG, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans AE. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996;89: 571-577.
20. Kang SS, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36:458-462.